News Center

Discover all of the trending news of the Ipsen Group


128 results

Event

Ipsen – Q1 Results – Conference Call – April 22, 2021

David Loew, Chief Executive Officer, is pleased to host a conference call to discuss the…

Group

Ipsen announces the arrival of Gwenan White, EVP Communicati...

We are pleased to announce the arrival of Gwenan White as Executive Vice President, Communications…

Rare diseases

A new language inviting you to understand more about the rar...

Language is fundamental to how we communicate with one another; it allows us to express…

Financial information

FY2020 financial results

In the face of the profound challenges and disruptions linked to the COVID-19 pandemic in…

Financial information

Ipsen – Full Year 2020 Results – Conference Call – Feb...

Ipsen is pleased to host a conference call to discuss the Group’s Year 2020 results…

Rare diseases

Why 2021 is the year for R&D progress

By Howard Mayer, M.D. - Executive Vice President, Head of Research and Development 2020…

Event

Ipsen – J.P Morgan Healthcare Conference – Thursday, January...

Date: Thursday, January 14, 2021 Time: Webcast – 10:00 Eastern time / 4:00pm CET Webcast…

CSR

Ipsen and the fight against corruption

Today is International Anti-Corruption Day. We are all aware that corruption has the potential to…

Event

Ipsen’s new strategic priorities unveiled at virtual Capital...

Today, Ipsen is hosting a virtual Capital Markets Day to launch our new Group strategy…

Event

Ipsen – Capital Markets Day Webcast – Tuesday, December 1, 2...

David Loew, Chief Executive Officer, is pleased to host a Capital Markets Day webcast…

Neuroscience

EACD 2020: How the use of functional assessments in clinical...

By Andreas Lysandropoulos MD, PhD, Vice President Head Global Medical Affairs Neuroscience at Ipsen An…

© Ipsen Pharma, 65 Quai Georges Gorse, 92100 Boulogne-Billancourt, France. All rights reserved - 2021